Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Sonoma Pharmaceuticals Inc SNOA

Healthcare
Sonoma Pharmaceuticals, Inc. is a global healthcare company, which is engaged in developing and producing stabilized hypochlorous acid (HOCl), products for a range of applications, including wound care, eye care, oral care, dermatological conditions, podiatry, animal health care and non-toxic disinfectants. The Company's product offerings include Lumacyn Clarifying Mist; Regenacyn Advanced Scar... see more

Recent & Breaking News (NDAQ:SNOA)

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sonoma Pharmaceuticals, Inc. - SNOA

GlobeNewswire December 7, 2020

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sonoma Pharmaceuticals, Inc. - SNOA

ACCESSWIRE IA December 5, 2020

IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces it is Investigating Claims Against Sonoma Pharmaceuticals, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm

ACCESSWIRE IA December 2, 2020

ROSEN, RESPECTED INVESTOR COUNSEL, Continues to Investigate Securities Claims Against Sonoma Pharmaceuticals, Inc. - SNOA

GlobeNewswire December 2, 2020

IMPORTANT INVESTOR NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Sonoma Pharmaceuticals, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm

ACCESSWIRE IA December 1, 2020

SONOMA PHARMACEUTICALS ALERT: Bragar Eagel & Squire, P.C. is Investigating Sonoma Pharmaceuticals, Inc. on Behalf of Sonoma Stockholders and Encourages Investors to Contact the Firm

GlobeNewswire November 30, 2020

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Sonoma Pharmaceuticals, Inc. - SNOA

GlobeNewswire November 30, 2020

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sonoma Pharmaceuticals, Inc. - SNOA

ACCESSWIRE IA November 29, 2020

INDIVIDUAL INVESTOR ALERT: ROSEN, GLOBAL INVESTOR COUNSEL, Investigates Securities Claims Against Sonoma Pharmaceuticals, Inc. Seeking Recovery of Investor Losses - SNOA

ACCESSWIRE IA November 27, 2020

IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces it is Investigating Claims Against Sonoma Pharmaceuticals, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm

ACCESSWIRE IA November 26, 2020

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sonoma Pharmaceuticals, Inc. - SNOA

PR Newswire November 25, 2020

Sonoma Pharmaceuticals, Inc. Investors: Company Investigated by the Portnoy Law Firm

GlobeNewswire November 25, 2020

Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Sonoma Pharmaceuticals, Inc. (SNOA) Investigation

ACCESSWIRE IA November 25, 2020

INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Sonoma Pharmaceuticals, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm

Newsfile November 25, 2020

ROSEN, A LEADING LAW FIRM, Continues to Investigate Securities Claims Against Sonoma Pharmaceuticals, Inc. - SNOA

PR Newswire November 24, 2020

INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Sonoma Pharmaceuticals, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm

Business Wire November 24, 2020

ROSEN, RESPECTED INVESTOR COUNSEL, Continues to Investigate Securities Claims Against Sonoma Pharmaceuticals, Inc. - SNOA

Newsfile November 24, 2020

EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Sonoma Pharmaceuticals, Inc. - SNOA

Business Wire November 24, 2020

Sonoma Pharmaceuticals Reports Second Quarter FY 2021 Financial Results

Business Wire November 20, 2020

Sonoma Pharmaceuticals and MicroSafe Group Announce that Health Canada Authorized Nanocyn® Disinfectant & Sanitizer to be Sold in Canada as a Hard-Surface Disinfectant under COVID-19 Interim Measure

Business Wire September 17, 2020